Tsiamis Ellie, Jorm Anthony, Neelakantan Lakshmi, Morgan Amy
Centre for Mental Health and Community Wellbeing, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Aust N Z J Psychiatry. 2025 Jun 24;59(8):48674251345318. doi: 10.1177/00048674251345318.
To identify Australian research priorities for clinical trials in child mental health (0-12 years).
A Delphi consensus study across three rounds was carried out with child mental health professional and lived experience experts. Potential research priorities for rating by the experts were identified from a rapid review; content analysis of government strategies and targeted calls for research; and panellists' suggestions. The highest rated priorities were then reduced to a smaller number of top priorities using a resource allocation exercise.
A total of 391 potential priorities were rated by 66 panellists. Panellists endorsed 75 priorities for trials covering a range of mental health interventions (promotion, prevention, assessment, and treatment), as well as overarching priorities applicable to all types of trials. The final resource allocation exercise refined these further to 12 top research priorities, including two promotion trial priorities, seven prevention and assessment trial priorities, and four treatment trial priorities.
Results will aid the Growing Minds Australia Clinical Trials Network's review, prioritisation, and endorsement of future clinical trials in child mental health. The findings can also be used to inform key stakeholders in child mental health on where clinical trial research efforts have focused in the past and what should be considered a priority in the future.
确定澳大利亚儿童心理健康(0至12岁)临床试验的研究重点。
与儿童心理健康专业人员和有实际经验的专家开展了三轮德尔菲共识研究。通过快速综述、政府战略内容分析及针对性研究呼吁以及小组成员的建议,确定了供专家评级的潜在研究重点。然后通过资源分配活动将评级最高的重点减少为数量更少的首要重点。
66位小组成员对总共391个潜在重点进行了评级。小组成员认可了75个适用于一系列心理健康干预措施(促进、预防、评估和治疗)试验的重点,以及适用于所有类型试验的总体重点。最终的资源分配活动将这些重点进一步细化为12个首要研究重点,包括两个促进试验重点、七个预防和评估试验重点以及四个治疗试验重点。
研究结果将有助于澳大利亚“成长心灵”临床试验网络对未来儿童心理健康临床试验进行审查、确定优先次序并予以认可。研究结果还可用于告知儿童心理健康领域的主要利益相关者,过去临床试验研究的重点所在以及未来应将哪些视为优先事项。